Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateMgmt Change15 Sept 2026

ASTRAZENECA PHARMA INDIA LIMITED

ASTRAZENECA PHARMA INDIA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

AstraZeneca Pharma India Limited has informed the BSE about the cessation of a director, Medical Affairs, Biopharmaceutical Business Unit, and Rare Disease Business Unit.

BSECompany UpdateMgmt Change15 Sept 2026

ASTRAZENECA PHARMA INDIA LIMITED

ASTRAZENECA PHARMA INDIA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

AstraZeneca Pharma India Limited has informed the BSE about the cessation of a director, specifically the Director - Medical Affairs, Biopharmaceutical Business Unit and Rare Disease Business Unit.

BSECompany UpdateMgmt Change15 Sept 2026

IFCI Limited

IFCI Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

IFCI Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change15 Sept 2026

IFCI Limited

IFCI Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

IFCI Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateFundraise15 Sept 2026

Mayur Leather Products Ltd

Bonanza Portfolio Limited ("Manager to the Offer") has submitted to BSE a copy of Public Announcement (''PA'') under Regulation 3(1) and 4 read with 13, 14 and 15(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereof for the attention of the Public Shareholders of Mayur Leather Products Ltd ("Target Company").

Mayur Leather Products Ltd has received a public announcement from Bonanza Portfolio Limited regarding an open offer for up to 12,57,048 equity shares, representing 26% of the company's equity and voting share capital, at an offer price of ₹27.92 per share.

Read more →📎 1 attachment
NSETrading WindowRegulatory15 Sept 2026

AstraZeneca Pharma India Limited

Trading Window

AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will be closed from September 16, 2026, and will reopen after 48 hours from the declaration of Un-audited Financial Results of the Company for the quarter and half year ending September 30, 2026.

Read more →📎 1 attachment
NSEAcquisitionJoint Venture15 Sept 2026

Thermax Limited

Acquisition

Thermax Limited has informed the Exchange about the incorporation of a wholly owned step-down subsidiary, Thermax Botswana Proprietary Limited, in Botswana.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updatesanalysts_institutional_investo15 Sept 2026

Bank of India

Analysts/Institutional Investor Meet/Con. Call Updates

Bank of India has informed the Exchange about an Analyst/Investor Meet as on 15-09-2026, where the bank's representative had a physical meeting with Phillip Capital, sharing only publicly available information and no unpublished price-sensitive information.

Read more →📎 1 attachment
BSECompany Update15 Sept 2026

Jupiter Life Line Hospitals Ltd

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.

Jupiter Life Line Hospitals Ltd has announced the schedule of analyst/institutional investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The meetings will be held on September 28, 2026, and will discuss publicly available information.

Read more →📎 1 attachment
NSEAppointmentMgmt Change15 Sept 2026

IFCI Limited

Appointment

IFCI Limited has appointed Mr. Dilip Singh Punia as a Non-Executive Independent Director on its board, effective September 11, 2026, for a period of three years.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesMgmt Change15 Sept 2026

L&T Technology Services Limited

Analysts/Institutional Investor Meet/Con. Call Updates

L&T Technology Services Limited has informed the Exchange about its participation in the Anand Rathi Annual Flagship Conference and G-200 Summit, where it will make a presentation on its business. The company has disclosed this information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change15 Sept 2026

Escorts Kubota Ltd

Intimation of Schedule of Analyst/ Investor Meet

Escorts Kubota Ltd has announced the schedule of an analyst/investor meet, which includes group meetings with various investors, a plant visit, and one-on-one meetings. The meet is scheduled from September 21 to 25, 2026, and no unpublished price-sensitive information will be shared.

Read more →📎 1 attachment
← PreviousPage 3794 of 9597Next →